Previous reports showed a higher prevalence of RASSF1 methylation in CRC (20–45%) (van Engeland et al, 2002; Wagner et al, 2002; Oliveira et al, 2005; Miranda et al, 2006). Here, RASSF1 is linked to colorectal carcinoma.